Why a new treatment for hRSV? Human respiratory syncytial virus (hRSV) is the leading cause of viral pneumonia,…
PI
Philip Santangelo & Tom Barker
Publications
Tiwari, P., Vanover, D., Lindsay, K., Bawage, S., Kirschman, J., Bhosle, S., Lifland, A., Zurla, C., Santangelo, P., “Engineered mRNA-Expressed Antibodies Prevent Respiratory Syncytial Virus Infection”, Nat Commun. 2018 Oct 1;9(1):3999. doi: 10.1038/s41467-018-06508-3. Blood 124(21):454-454. DOI: 10.1182/blood. V124.21.454.454.
Research Area